<DOC>
	<DOCNO>NCT01289652</DOCNO>
	<brief_summary>The aim study investigate epidemiology , natural history treatment outcomes acute hepatitis C ( HCV ) infection . Given current pattern case reporting , cohort largely make human immunodeficiency virus ( HIV ) -positive patient , HIV-negative patient acute hepatitis C ( AHC ) also enrol enable comparison make appropriate possible .</brief_summary>
	<brief_title>The Natural History Treatment Acute Hepatitis C Virus ( HCV ) HIV-positive Individuals</brief_title>
	<detailed_description>In multi-center , prospective , open cohort study , patient document acute hepatitis C infection follow prospectively initial time-period 3 year diagnosis acute hepatitis C infection investigate : 1. epidemiology - describe characteristic patient acquire acute HCV infection , include examination regional difference mode transmission , behavioural factor , concomitant sexually transmit disease , clinical presentation associate laboratory test result . - characterization HCV strain circulate within community use phylogenetic analysis 2. natural history - determination rate spontaneous viral clearance , clinical , immunological , host genetic viral factor associate viral clearance - progression liver disease acute hepatitis C ; include use non-invasive liver fibrosis marker estimate rate liver fibrosis progression 3. treatment strategy - describe outcome different treatment strategy acute HCV infection , although acknowledged random allocation treatment strategy . - investigate factor associate treatment response include time initiation therapy , duration therapy , use ribavirin genetic factor .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Documented current past acute hepatitis C infection detectable HCVRNA ( PCRassay ) estimate duration 52 week diagnosis define : First HCV RNA positive AND Prior negative antiHCV antibody HCV RNA test within 12 month OR Rise liver transaminases 2.5 x upper limit normal ( ULN ) within past 12 month prior normal transaminase year AND Exclusion cause acute hepatitis Acute liver disease hepatitis C Inability provide write informed consent Younger 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Acute hepatitis C ( HCV )</keyword>
	<keyword>Human immunodeficiency virus ( HIV )</keyword>
</DOC>